|
TP1545L1 |
FFAGLDD amine salt
|
|
Others
|
|
FFAGLDD amine salt is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release. |
|
T17946 |
Fmoc-Ala-Ala-Asn(Trt)-OH
|
|
Others
|
|
Fmoc-Ala-Ala-Asn(Trt)-OH is a cleavable linker vital in ADC synthesis. Fmoc-Ala-Ala-Asn(Trt)-OH joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled... |
|
T4271 |
Diroximel fumarate
|
Diroximel Fumarete |
Others
|
|
Diroximel fumarate (Diroximel Fumarete), a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body. |
|
T17524 |
Azidoethyl-SS-propionic acid
|
|
Others
|
|
Azidoethyl-SS-propionic acid is an ADC linker, specifically designed for the synthesis of antibody-drug conjugates (ADCs)[1]. It possesses cleavable properties, allowing for the controlled release of drug payloads. |
|
T38597 |
SPDP-sulfo
|
|
|
|
SPDP-sulfo is a cleavable linker vital in ADC synthesis. SPDP-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing AD... |
|
T17836 |
DMAC-SPP
|
|
Others
|
|
DMAC-SPP is a cleavable linker vital in ADC synthesis. DMAC-SPP joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ADC ef... |
|
T18732 |
Sulfo-SPDB
|
|
Others
|
|
sulfo-SPDB is a cleavable linker vital in ADC synthesis. sulfo-SPDB joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing AD... |
|
T39538 |
BCOT-PEF3-OPFP
|
BCOT-PEF3-OPFP |
|
|
BCOT-PEF3-OPFP is a cleavable linker vital in ADC synthesis. BCOT-PEF3-OPFP joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optim... |
|
T18559 |
PPC-NHS ester
|
2,5-Dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate |
Others
|
|
PPC-NHS ester is a cleavable linker vital in ADC synthesis. PPC-NHS ester joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T18503 |
NHS-SS-biotin
|
|
Others
|
|
NHS-SS-biotin is a cleavable linker vital in ADC synthesis. NHS-SS-biotin joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T39023 |
Biotin-sar-oh
|
|
|
|
Biotin-sar-oh is a cleavable linker vital in ADC synthesis. Biotin-sar-oh joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T40764 |
DMAC-SPDB
|
|
|
|
DMAC-SPDB is a cleavable linker vital in ADC synthesis. DMAC-SPDB joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ADC ... |
|
T39880 |
Propargyl-Tos
|
|
|
|
Propargyl-Tos is a cleavable linker vital in ADC synthesis. Propargyl-Tos joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T14724 |
Boc-Cystamine
|
|
Others
|
|
Boc-Cystamine is a cleavable linker vital in ADC synthesis. Boc-Cystamine joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T40761 |
NO2-SPP-sulfo
|
NO2-SPP-sulfo |
|
|
NO2-SPP-sulfo is a cleavable linker vital in ADC synthesis. NO2-SPP-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T17540 |
BCN-SS-NHS
|
|
Others
|
|
BCN-SS-NHS is a cleavable linker vital in ADC synthesis. BCN-SS-NHS joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing AD... |
|
T15927 |
M-PEG8-Amine
|
|
Others
|
|
m-PEG8-Amine is a cleavable linker vital in ADC synthesis. m-PEG8-Amine joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizin... |
|
T18786 |
TCO-SS-amine
|
|
Others
|
|
TCO-SS-amine is a cleavable linker vital in ADC synthesis. TCO-SS-amine joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizin... |
|
T40763 |
NO2-SPDMV-sulfo
|
NO2-SPDMV-sulfo |
|
|
NO2-SPDMV-sulfo is a cleavable linker vital in ADC synthesis. NO2-SPDMV-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, opt... |
|
T39087 |
MC-VC-PAB-NH2
|
MC-VC-PAB-NH2 |
|
|
MC-VC-PAB-NH2 is a cleavable linker vital in ADC synthesis. MC-VC-PAB-NH2 joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T39169 |
Tetrazine-biotin
|
|
|
|
Tetrazine-biotin is a cleavable linker vital in ADC synthesis. Tetrazine-biotin joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, o... |
|
T18505 |
NO2-SPDMV
|
|
Others
|
|
NO2-SPDMV is a cleavable linker vital in ADC synthesis. NO2-SPDMV joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ADC ... |
|
T17835 |
DMAC-PDB
|
|
Others
|
|
DMAC-PDB is a cleavable linker vital in ADC synthesis. DMAC-PDB joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ADC ef... |
|
T63434 |
Abiraterone decanoate
|
|
|
|
Abiraterone decanoate is a prodrug of Abiraterone that provides controlled release and long-lasting CYP17 inhibition of Abiraterone using intramuscular (IM) delivery. |
|
T40765 |
DMAC-SPDB-sulfo
|
|
|
|
DMAC-SPDB-sulfo is a cleavable linker vital in ADC synthesis. DMAC-SPDB-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, opt... |
|
T17539 |
BCN-SS-amine
|
|
Others
|
|
BCN-SS-amine is a cleavable linker vital in ADC synthesis. BCN-SS-amine joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizin... |
|
T40762 |
NO2-SPDB-sulfo
|
NO2-SPDB-sulfo |
|
|
NO2-SPDB-sulfo is a cleavable linker vital in ADC synthesis. NO2-SPDB-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optim... |
|
T17812 |
DBCO-SS-amine
|
|
Others
|
|
DBCO-SS-amine is a cleavable linker vital in ADC synthesis. DBCO-SS-amine joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimiz... |
|
T14516 |
BDP FL DBCO
|
|
Others
|
|
BDP FL DBCO is a cleavable linker vital in ADC synthesis. BDP FL DBCO joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ... |
|
T40726 |
Azide-C2-Azide
|
Azide-C2-Azide |
|
|
Azide-C2-Azide is a cleavable linker vital in ADC synthesis. Azide-C2-Azide joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optim... |
|
TP1498 |
FFAGLDD TFA
|
|
|
|
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release. |
|
T17386 |
Alkyne-PEG4-SS-PEG4-alkyne
|
|
Others
|
|
Alkyne-PEG4-SS-PEG4-alkyne is an eight-unit polyethylene glycol (PEG) linker, designed for antibody-drug conjugates (ADCs) synthesis, that can be cleaved. This linker serves as a connection between the antibody and the d... |
|
T18350 |
Methyltetrazine-PEG4-oxyamine
|
|
Others
|
|
Methyltetrazine-PEG4-oxyamine is a 4-unit polyethylene glycol (PEG) linker employed in the synthesis of antibody-drug conjugates (ADCs), which are extensively used for targeted drug delivery [1]. This cleavable linker of... |
|
TP1545 |
FFAGLDD
|
|
Others
|
|
FFAGLDD is a peptide selective for MMP9 cleavage, utilized for the cytosolic delivery of Doxorubicin (DOX) to achieve controlled, gradual drug delivery and release both temporally and spatially. |
|
T18521 |
PC DBCO-PEG3-biotin
|
|
Others
|
|
PC DBCO-PEG3-biotin is a trimeric polyethylene glycol (PEG) linker, specifically designed for antibody-drug conjugate (ADC) synthesis, with a cleavable moiety consisting of a dibenzocyclooctyne (DBCO) group and a biotin ... |
|
T38503 |
(2-pyridyldithio)-PEG1-hydrazine
|
(2-pyridyldithio)-PEG1-hydrazine |
|
|
(2-Pyridyldithio)-PEG1-hydrazine is a one-unit cleavable polyethylene glycol (PEG) linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This linker offers the advantage of controlled release... |
|
T18522 |
PC Mal-NHS carbonate ester
|
|
Others
|
|
PC Mal-NHS carbonate ester is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs)[1]. This chemical compound plays a crucial role in facilitating the conjugation of drugs to anti... |
|
T74437 |
β-Glucuronide-dPBD-PEG5-NH2
|
|
|
|
β-Glucuronide-dPBD-PEG5-NH2 is a β-glucuronide-linked pyrrolobenzodiazepine dimer that functions as a proagent for the synthesis of the antibody-drug conjugate (ADC) cIRCR201-dPBD, utilizing a cleavable β-glucuronide lin... |
|
T83742 |
SBP1 TFA
|
Spike Binding Peptide 1 |
|
|
Spike Binding Peptide 1 (SBP1), representing amino acids 21-43 of angiotensin-converting enzyme 2 (ACE2), has been utilized in a novel approach involving lipid nanoparticles (LNPs) encapsulated with oseltamivir phosphate... |
